George Yancopoulos, EVP, CSO, & President Regn Res Labs at REGENERON PHARMACEUTICALS INC (REGN), sold 74,859 shares at $16.40 ($1.2M) on 2008-12-16, disclosed to the SEC on 2008-12-18.
Scheduled sale ($1.2M) by EVP, CSO, & President Regn Res Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.40 | 26,991 | $443K | 36.0% |
| 2 | $16.42 | 14,922 | $245K | 19.9% |
| 3 | $16.42 | 32,946 | $541K | 44.0% |
| Total | $16.41 avg | 74,859 | $1.2M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |